Treat mild hypercalcemia by reducing or interrupting Once-a-Day ) acetate and Vitamin D. Capsule: 667 mg Once-a-Day (Calcium (Calcium Phosphate Tribasic)) acetate capsule. (2)Ĭapsule: 667 mg Once-a-Day (Calcium (Calcium Phosphate Tribasic)) acetate capsule. Most patients require 3 to 4 capsules with each meal. Titrate the dose every 2 to 3 weeks until acceptable serum phosphorus level is reached. Starting dose is 2 capsules with each meal. Increase the dose gradually to lower serum phosphorus levels to the target range, as long as hypercalcemia does not develop. The recommended initial dose of Once-a-Day (Calcium (Calcium Phosphate Tribasic)) acetate for the adult dialysis patient is 2 capsules with each meal. Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. Once-a-Day (Calcium (Calcium Phosphate Tribasic)) acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).
0 Comments
Leave a Reply. |